Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US.

Dong, Huiru; Stringfellow, Erin J; Russell, W Alton; Jalali, Mohammad S

Dong, Huiru; Stringfellow, Erin J; Russell, W Alton; Jalali, Mohammad S.

Afiliação

Dong H; Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts.
Stringfellow EJ; Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts.
Russell WA; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Jalali MS; Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts.

JAMA Psychiatry ; 80(1): 93-95, 2023 01 01.

Article em En | MEDLINE | ID: mdl-36350592

This cohort study examines racial and ethnic differences in the duration of buprenorphine treatment for opioid use disorder in the US from 2006 to 2020.

Assuntos

Buprenorfina; Transtornos Relacionados ao Uso de Opioides; Humanos; Estados Unidos; Buprenorfina/uso terapêutico; Duração da Terapia; Grupos Raciais; Etnicidade; Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico; Disparidades nos Níveis de Saúde

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: JAMA Psychiatry Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google